Archives: Commentaries

Current cholesterol guidelines promote the use of statins as first line therapy in primary and secondary prevention of atherosclerotic cardiovascular disease (ASCVD) events. Despite the impressive risk reduction associated with...

The treatment options for type 2 diabetes mellitus (T2DM) have increased dramatically over the past decade. Despite these advancements, treatment recommendations remain largely unchanged. The American Diabetes Association (ADA)...

The American Heart Association reports that 1 out of 3 adults in the Unites States have high blood pressure and the direct and indirect costs exceeded $50 billion in 2009.  Clearly we need to develop a variety of approaches...

          Digoxin is FDA-approved for the treatment of mild to moderate heart failure (HF) as well as the control of resting ventricular rate in adult patients with chronic atrial fibrillation (AF).1...

  Heart failure not only causes disability and death but also millions of hospitalizations each year.1  The standard of care for patients with heart failure with reduced ejection fraction (HFrEF) includes a cocktail of...

Have you ever had difficulty convincing some of your patients that generic medications work just as well as their brand-name counterparts?  While there is little evidence to suggest that generic medications aren’t...

Telecare — providing care to patients using a variety of communication technologies — has been touted as a win-win strategy for providers and patients that improves clinical outcomes at a lower cost. Systematic reviews have...

Your patients with diabetes may have heard through the grapevine about resveratrol to control blood sugar.  Indeed, a recent meta-analysis concluded that dietary supplements containing resveratrol significantly lowers blood...